Snap-on Operating Cash Flow increased by 37.5% to $368.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.5%, from $298.50M to $368.70M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 2.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $319.30M | $238.20M | $186.40M | $222.70M | $193.90M | $140.80M | $129.90M | $210.60M | $301.60M | $270.30M | $285.40M | $296.90M | $348.70M | $301.10M | $274.20M | $293.50M | $298.50M | $237.20M | $277.90M | $268.10M | $368.70M |
| QoQ Change | — | -25.4% | -21.7% | +19.5% | -12.9% | -27.4% | -7.7% | +62.1% | +43.2% | -10.4% | +5.6% | +4.0% | +17.4% | -13.7% | -8.9% | +7.0% | +1.7% | -20.5% | +17.2% | -3.5% | +37.5% |
| YoY Change | — | — | — | — | -39.3% | -40.9% | -30.3% | -5.4% | +55.5% | +92.0% | +119.7% | +41.0% | +15.6% | +11.4% | -3.9% | -1.1% | -14.4% | -21.2% | +1.3% | -8.7% | +23.5% |